Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Innovative EyewearLUCY -8.17%57 3-Year ROIIC % is -142.06 as of Dec. 2025. GuruFocus rates LUCY with a GF Score™ of 57/100 and a GF Value™ of $1.80 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Innovative Eyewear ranks worse than 89.18% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Innovative Eyewear's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -142.06%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Innovative Eyewear's 3-Year ROIIC % or its related term are showing as below:
LUCY's 3-Year ROIIC % is ranked worse than 89.18% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs LUCY: -142.06
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Innovative Eyewear 3-Year ROIIC % Related Terms
Innovative Eyewear 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Innovative Eyewear's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LUCY vs NXGL, CBSC, RSCF: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Innovative Eyewear's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovative Eyewear 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Innovative Eyewear's 3-Year ROIIC % falls into.
Innovative Eyewear's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -8.495 (Dec. 2025) - -5.577 (Dec. 2022) )
/
( 2.644 (Dec. 2025) - 0.59 (Dec. 2022) )
=
-2.918
/
2.054
=
-142.06%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Innovative Eyewear (LUCY) has a 3-Year ROIIC % of -142.06 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Innovative Eyewear and its competitors. According to the industry distribution chart, Innovative Eyewear ranks #709 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 89.2%.
Is Innovative Eyewear's 3-Year ROIIC % too high?
Innovative Eyewear's current 3-Year ROIIC % is -142.06. Based on the distribution chart, Innovative Eyewear ranks #709 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Innovative Eyewear has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Innovative Eyewear's 3-Year ROIIC % compare to NXGL and CBSC?
According to the Medical Devices & Instruments industry distribution chart, Innovative Eyewear ranks #709 out of 795 companies for 3-Year ROIIC %. This places Innovative Eyewear in the lower half of its industry. The industry median 3-Year ROIIC % is 1.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Innovative Eyewear and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovative Eyewear's current 3-Year ROIIC % is -142.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovative Eyewear stock overvalued right now?
Based on GuruFocus' analysis, Innovative Eyewear (LUCY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.80, compared to a current price of $0.73 — trading 59.2% below its estimated fair value. The current 3-Year ROIIC % is -142.06. Innovative Eyewear's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Innovative Eyewear (LUCY), the current 3-Year ROIIC % is -142.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innovative Eyewear (LUCY) Overvalued in 2026?
Based on GuruFocus' analysis, Innovative Eyewear stock appears to be undervalued.
The current stock price of $0.73 is trading 59.2% below its estimated GF Value™ of $1.80.
GuruFocus considers Innovative Eyewear to be Possible Value Trap.
Key valuation signals for LUCY:
3-Year ROIIC %: -142.06
GF Value™: $1.80 vs. price of $0.73 (59.2% below fair value)
No single metric tells the full story. See the LUCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
57GF Score
Get the complete analysis for LUCY
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUCY has been successfully added to your 
